/

Batteries & E-Mobility

/

Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Sunnyvale, California

·

Since 1991

Pharmacyclics, a biopharmaceutical company headquartered in Sunnyvale, California, was founded in 1991 and has been a wholly owned subsidiary of AbbVie since 2015. The firm employs 500–1,000 people and generates estimated revenue between $1–5 billion annually. It develops small-molecule therapies for cancer and immune-mediated diseases, serving the oncology and medical sectors. The company's flagship product, Imbruvica, treats B-cell cancers including chronic lymphocytic leukemia and mantle cell lymphoma.

Pharmacyclics, an AbbVie Company

Verified Nov 2026

AT A GLANCE

Founded

1991

Headquarters

United States flag

Sunnyvale, California

Employees

500-1,000

Ownership

Pharmacyclics, an AbbVie Company at a glance

Revenue

$1-5B

Est. band

Employees

500-1,000

Founded

1991

Headquarters

Sunnyvale, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Pharmacyclics, a biopharmaceutical company headquartered in Sunnyvale, California, was founded in 1991 and has been a wholly owned subsidiary of AbbVie since 2015. The firm employs 500–1,000 people and generates estimated revenue between $1–5 billion annually. It develops small-molecule therapies for cancer and immune-mediated diseases, serving the oncology and medical sectors. The company's flagship product, Imbruvica, treats B-cell cancers including chronic lymphocytic leukemia and mantle cell lymphoma.

At a glance

Attribute

Detail

Founded

1991

Headquarters

Sunnyvale, California

Employees

500-1,000

Revenue

$1-5B (estimated)

Primary capability

Batteries & E-Mobility

What Pharmacyclics, an AbbVie Company makes

Pharmacyclics maintains a pipeline of over 200 clinical trials spanning more than 20 cancer types, focusing on small-molecule oncology therapies and immune-mediated disease treatments.

Latest developments

Facilities

Pharmacyclics, an AbbVie Company is headquartered in Sunnyvale, California. Public sources also reference these locations:

Company details

As a subsidiary of AbbVie, Pharmacyclics leverages its parent company's extensive commercial network to distribute its therapies globally to cancer patients. Pharmacyclics, an AbbVie Company was founded in 1991, has an estimated 500-1,000 employees, and is headquartered in Sunnyvale, California.

Frequently asked questions

What does Pharmacyclics, an AbbVie Company make?

Pharmacyclics, a biopharmaceutical company headquartered in Sunnyvale, California, was founded in 1991 and has been a wholly owned subsidiary of AbbVie since 2015. The firm employs 500–1,000 people and generates estimated revenue between $1–5 billion annually. It develops small-molecule therapies for cancer and immune-mediated diseases, serving the oncology and medical sectors. The company's flagship product, Imbruvica, treats B-cell cancers including chronic lymphocytic leukemia and mantle cell lymphoma.

Where is Pharmacyclics, an AbbVie Company headquartered?

Pharmacyclics, an AbbVie Company is headquartered in Sunnyvale, California (999 East Arques Avenue, Sunnyvale, California, 94085).

When was Pharmacyclics, an AbbVie Company founded?

Pharmacyclics, an AbbVie Company was founded in 1991.

How big is Pharmacyclics, an AbbVie Company?

Pharmacyclics, an AbbVie Company has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Sunnyvale, California (HQ)Headquarters · United States
Sunnyvale, California (HQ)999 East Arques Avenue, Sunnyvale, California, 94085, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.